Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

AI professor who survived cancer turns talents to war on COVID

As an academic AI expert, Pascale Fung, PhD, dove into the scientific research when she was diagnosed with breast cancer in 2015. The time investment rewarded her with a depth of understanding that has helped shape her life as a cancer survivor.

Neural networks refreshed by virtual sleep

Researchers have found that spiking neural networks become unstable after unbroken periods of unsupervised self-training. Moreover, these “artificial brains” seem to restabilize after they’re given the equivalent of a good night’s rest.

Thumbnail

How AI is speeding up COVID-19 diagnosis

AI is stepping in to help speed up the diagnosis of COVID-19 and expedite how much time healthcare professionals spend determining COVID-19 pneumonia and non-COVID-19 cases.

AI takes aim at 158-year-old eye exam

It may be time to take a long last look at the vision exam that relies on a cardboard sheet of huge letters at the top and tiny ones at the bottom.

Thumbnail

WHO’s hydroxychloroquine trial will resume

The World Health Organization announced it will resume a clinical trial evaluating the efficacy of hydroxychloroquine for COVID-19 patients after the organization halted it following studies showing higher risks to patients taking the drug.

AI patient monitoring included in proposed emergency-response system

U.S. Army researchers are calling for the creation of a national emergency network that would coordinate select digital health technologies, including AI, in fighting COVID-19 now and other public health crises later.

American health IT giant working to launch AI research center in the Middle East

Cerner is partnering with 252-bed American Hospital Dubai to open a medical AI research center in the United Arab Emirates.

Thumbnail

The Lancet corrects hydroxychloroquine paper after backlash

The Lancet has issued four corrections to a research paper that found COVID-19 patients who used the drug hydroxychloroquine have a higher risk of death.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup